Advice
In the absence of a submission from the holder of the marketing authorisation
celecoxib (Celebrex®) is not recommended for use within NHSScotland for ankylosing spondylitis.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice24KB (PDF)
Medicine details
- Medicine name:
- celecoxib (Celebrex)
- SMC ID:
- 410/07
- Indication:
- ankylosing spondylitis.
- Pharmaceutical company
- Pfizer Ltd
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 10 September 2007